Amplitude Hits New 52-Week High on Better-Than-Expected Earnings

What happened

Amplitude shares surged to a new 52-week high of $18.50 after the company reported better-than-expected quarterly earnings on November 6, 2026, closing near $17.89, up from the prior close of $17.19. This represents nearly a doubling from the ~$9.17 price level reflected in the DeepValue report snapshot from late January 2026, far exceeding the report's bull case value of $14. The earnings beat likely validates the AI-driven growth thesis, with continued strong ARR growth and improving profitability metrics, though details are truncated in the news snippet. The stock now trades well above the report's trim threshold of $13.50, indicating that the margin of safety has been largely consumed. This move signals that the market is pricing in sustained mid-teens or better growth with expected margin expansion.

Implication

The price now sits substantially above the DeepValue report's attractive entry point of $8.50 and even above its bull case of $14, meaning the risk-reward has deteriorated sharply. While better-than-expected earnings support the AI-driven growth narrative, the stock likely trades at a much higher revenue multiple, leaving little room for execution missteps. Investors should wait for a pullback toward the $13-14 range before considering new positions, as that level still implies a premium to the original base case. If the earnings beat was driven by durable acceleration in ARR growth and non-GAAP profitability, fair value may have shifted higher, but we need detailed metrics to confirm. Until then, disciplined position sizing and profit-taking are prudent for existing shareholders.

Thesis delta

The original thesis was a potential buy at ~$9 with a base case of $11.50 and a bull case of $14. The stock's surge to $18+ on better-than-expected earnings suggests the bull scenario is unfolding or even being exceeded, but at current prices the margin of safety is gone. The thesis shifts from an undervalued turnaround to a momentum story at a rich valuation, requiring confirmation of fundamental durability before further upside is underwritten.